| TPT | tetraphenyl tetrazolium; triphalangeal thumb; total protein tuberculin; typhoid-paratyphoid [vaccine... |
|---|---|
| TV | talipes varus; television; tetrazolium violet; thoracic vertebra; tickborne virus; tidal volume; tot... |
| HBPV | Haemophilus influenza type B Polysaccharide(PRP) Vaccine; B형 헤모필루스 인플루엔자 피막 다당질 백신... |
| PPV | pneumococcal polysaccharide vaccine; porcine parvovirus; positive predictive value; positive pressur... |
| TD | tabes dorsalis; tardive dyskinesia; T-cell dependent; temporary disability; terminal device; tetanus... |
| equine typhoid | A highly contagious viral disease caused by equine arteritis virus, member of the family Togaviridae, and characterised by a high fever and respiratory and digestive tract signs; the essential lesions involve smaller arteries, with necrosis which may be followed by thrombosis, infarction, haemorrhages, and oedema; abortion is a common result. Synonym: epizootic cellulitis, equine typhoid. (05 Mar 2000) |
|---|---|
| typhoid | <disease, microbiology> An infectious febrile illness usually spread by contamination of food, milk or water supplies with Salmonella typhi, either directly by sewage, indirectly by flies or by faulty personal hygiene. There are less than 600 cases per year in the US. Asymptomatic carriers harbor the organism in their gallbladder and excrete it in their stools for years. Average incubation time is 10-14 days. Fever, diarrhoeal stools (often bloody), abdominal pain, malaise and a rose coloured rash on the upper abdomen are seen. Severe cases may progress to delirium and obtundation. Complications include glomerulonephritis. Treatment includes intravenous fluids and antibiotics (chloramphenicol or ampicillin). Vaccines are recommended for travel to endemic areas. (27 Sep 1997) |
| typhoid bacillus | A serotype of salmonella enterica which is the aetiologic agent of typhoid. (12 Dec 1998) |
| typhoid bacteriophage | Bacteriophage specific for Salmonella typhi. (05 Mar 2000) |
| typhoid cholera | Old term for cholera with predominantly cerebral manifestations such as confusion or dementia. (05 Mar 2000) |
| typhoid fever | <disease, microbiology> An infectious febrile illness usually spread by contamination of food, milk or water supplies with Salmonella typhi, either directly by sewage, indirectly by flies or by faulty personal hygiene. There are less than 600 cases per year in the us. Asymptomatic carriers harbor the organism in their gallbladder and excrete it in their stools for years. Average incubation time is 10-14 days. Fever, diarrhoeal stools (often bloody), abdominal pain, malaise and a rose coloured rash on the upper abdomen are seen. Severe cases may progress to delirium and obtundation. Complications include glomerulonephritis. Treatment includes intravenous fluids and antibiotics (chloramphenicol or ampicillin). Vaccines are recommended for travel to endemic areas. (27 Sep 1997) |
| typhoid pleurisy | An obsolete term for acute or subacute pleurisy with typhoid symptoms. (05 Mar 2000) |
| typhoid pneumonia | Pneumonia complicating typhoid fever. (05 Mar 2000) |
| typhoid septicaemia | Typhoid during the phase when the organism can be cultured from the blood. Synonym: typhosepsis. (05 Mar 2000) |
| latent typhoid | walking typhoid |
| fowl typhoid | A septicaemic disease of chickens and turkeys, caused by Salmonella gallinarum; some human infections with this organism have been reported. (05 Mar 2000) |
| acellular vaccine | <immunology, pharmacology, virology> Vaccine consisting of antigenic parts of cells. (13 Nov 1997) |
| adjuvant vaccine | A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate). (05 Mar 2000) |
| aqueous vaccine | A vaccine having a liquid vehicle (e.g., physiological salt solution) as distinguished from an emulsion. (05 Mar 2000) |
| attenuated vaccine | Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine. (05 Mar 2000) |